Measles virus cancer therapy shows promise, prompts caution

Mayo Clinic researchers stirred excitement by saying they had treated a patient’s blood cancer with a specially engineered measles virus, but even scientists involved in the work caution the response does not prove they have a cure. Dr. Stephen Russell, the report's lead author and a hematologist at the Mayo Clinic, and his colleagues write in the journal Mayo Clinic Proceedings that multiple myeloma‎ in a 49-year-old woman seemed to disappear after she received an extremely high-dose injection of a measles virus engineered to kill the cancer cells. Read more here.